Skip to main content
Clinical Trials/NCT04854577
NCT04854577
Unknown
N/A

The Postoperative Opioid-Sparing Effect of an Intraoperative Pecto-Intercostal Fascial Block and Opioid-Free Anesthesia in Cardiac Surgery Patients: a Prospective Randomized Controlled Trial

Algemeen Stedelijk Ziekenhuis0 sites64 target enrollmentMay 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Opioid Free Anaesthesia
Sponsor
Algemeen Stedelijk Ziekenhuis
Enrollment
64
Primary Endpoint
Postoperative morphine consumption
Last Updated
5 years ago

Overview

Brief Summary

The present study aims to assess the difference in postoperative opioid consumption between patients who intraoperatively receive a pecto-intercostal facial block combined with opioid-free anesthesia versus a traditional opioid-based regimen for cardiac surgery. The literature on opioid-free anesthesia for cardiac surgery is minimal and solely consists of case reports and retrospective studies. Nevertheless, these reports show the feasibility of opioid-free anesthesia. The purpose of this study is to assess the opioid-sparing effect and efficacy of combining an opioid-free anesthetic regimen with a pecto-intercostal fascial plane block (PIFB) in patients undergoing cardiac surgery.

We hypothesize that opioid-free cardiac anesthesia with an intraoperative PIFB significantly reduces postoperative opioid consumption in comparison to a high-dose opioid intraoperative regimen.

Detailed Description

Patients, aged 18 years or older, scheduled for coronary artery bypass graft surgery (CABG) with a complete midline sternotomy as surgical approach will be recruited for this study. Patients planned for this particular surgical procedure will be recruited and allocated to one of 2 groups: 1. "Intervention" group: Opioid-free anesthetic regimen with a pre-incisional pecto-intercostal fascial plane block (PIFB); 2. "Control" group: traditional opiate-based anesthetic regimen in which the dosage of the opioids is at the discretion of the attending anesthesiologist. Based on our power analysis, each group will consist of 64 patients.

Registry
clinicaltrials.gov
Start Date
May 2021
End Date
September 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Algemeen Stedelijk Ziekenhuis
Responsible Party
Principal Investigator
Principal Investigator

Koen Lapage, M.D.

Consultant Anesthesiology

Algemeen Stedelijk Ziekenhuis

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years or older
  • Patients scheduled for coronary artery bypass graft surgery (CABG), which includes a complete midline sternotomy.

Exclusion Criteria

  • CABG surgery which did not include a complete midline sternotomy
  • Valve surgery
  • Aortic surgery
  • Emergency cardiac surgery
  • Known allergy for ropivacaine
  • Participation in another clinical trial
  • Known drug abuse
  • Preoperative cognitive dysfunction
  • Preoperative pain therapy with opioids or anticonvulsants 14 days before surgery
  • Patients unable to use Patient Controlled Analgesia (PCA)

Outcomes

Primary Outcomes

Postoperative morphine consumption

Time Frame: Day 2

The total amount of morphine used postoperatively in the intensive care unit until discharge.

Secondary Outcomes

  • Mean length of ICU stay(Day 2)
  • Time until extubation(Day 0)
  • Mean visual analogue score (VAS) pain score at rest(Day 2)
  • Mean visual analogue score (VAS) pain score whilst coughing(Day 2)
  • Incidence of postoperative nausea and vomiting(Day 2)
  • Incidence of postoperative delirium(Day 2)

Similar Trials